• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Virtual Reality Relief for Workers’ Compensation: AppliedVR Launches RelieVRx® Program

by Jasmine Pennic 05/22/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
AppliedVR Releases Clinical Trial Results from In-Home Virtual Reality Program for Chronic Lower Back Pain

What You Should Know: 

– AppliedVR, a leader in immersive therapeutic solutions, has announced the launch of their flagship product, RelieVRx®, into the workers’ compensation market. This FDA-authorized virtual reality (VR) program is the first of its kind to offer comprehensive, non-pharmacological treatment for chronic lower back pain (CLBP

– AppliedVR’s RelieVRx® program signifies a significant advancement in pain management for workers’ compensation claims.  

A Non-Pharmacological Approach to Pain Management

RelieVRx® stands out as the first comprehensive, immersive VR treatment specifically designed to address CLBP in workers’ compensation cases. This non-pharmaceutical pain therapy provides a cost-effective and convenient option for injured workers.

The RelieVRx device provides a safe and effective alternative to traditional pain management methods. Here’s what makes it unique:

  • Immersive VR Experience: Patients learn valuable skills through a fully immersive VR experience, empowering them to actively manage and reduce their pain.
  • Cost-Effective and Non-Pharmacological: RelieVRx offers a cost-effective solution without the use of medications, potentially reducing long-term healthcare costs.
  • Clinically Proven Results: Studies have shown that RelieVRx leads to clinically significant reductions in pain intensity and its impact on daily activities, sleep, mood, and stress. These positive effects are sustained even two years after treatment completion.

Immersive Therapy from Home

Workers can utilize RelieVRx® from the comfort of their homes. The program features 56 interactive VR chapters, each approximately six minutes long. These sessions progressively build upon each other, promoting neuroplasticity – the brain’s ability to reorganize neural pathways associated with pain perception.  AppliedVR’s innovative VR solution offers a safe, effective, and convenient option for reducing chronic lower back pain and improving overall well-being.

“The RelieVRx program is a safe and effective alternative to common treatment modalities without any of the risks that opioids and surgeries carry,” said AppliedVR’s Co-Founder and President Josh Sackman. “We believe this program will receive broad acceptance in the workers’ comp community.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: AppliedVR, Augmented Reality, Virtual Reality

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |